Nicole Lee
李慧铭
LL.B. (HONS) (Bristol)
Associate Director
“Live a life centred by humility, kindness and grace.”
Nicole made the choice to pivot into corporate work after three years' training with the litigation and dispute resolution department at one of Singapore’s largest firms. There, she found that the grass was indeed greener on the other side and has not looked back.
Nicole has since built a practice in private and public mergers and acquisitions and general corporate work, which includes advising and acting on cross-border and domestic transactions involving investments, joint ventures, and share and business sale transactions.
Her well-rounded training has developed her into a versatile lawyer with the ability to analyse various perspectives. Purpose-driven, quick-witted and affable, Nicole has over time earned the trust of her clients and colleagues alike.
Outside of work, Nicole enjoys travelling and believes that the world is best travelled on foot, one hiking trail at a time. She likens hiking to her career thus far – the journey is long and painful, and when giving up comes to mind, press on regardless, you will find that the views are oftentimes worthwhile.
Nicole was recognised by Singapore Business Review as one of Singapore's Most Notable Lawyers under 40, in 2025.
Notable Briefs
Acted as transaction counsel for the largest and most diverse property developer in Indonesia in its investment into 2 coal mines in Indonesia.
Acted as transaction counsel for utu Pte Ltd, a travel-tech firm, in its acquisition of 100% of the shares in CardsPal, a Singapore-based platform offering hyper-localised rewards, from SC Ventures (Standard Chartered’s fintech and ventures arm) and in its Series B funding round. The combined transaction value of the acquisition and the funding round was S$33 million.
Acted as Singapore counsel for global investment firm KKR & Co in its acquisition of 20% stake (valued at S$1.1 billion) in Singtel’s regional data centre business.
Acted as Singapore counsel to Apollo, one of the largest global asset managers, in its investment in PanAsia Health Limited, the holding company of Health Management International Pte Ltd (“HMI”), a private healthcare provider with regional presence in Singapore, Malaysia and Indonesia. Among other medical facilities, HMI owns the largest private ophthalmology group in Singapore, Eagle Eye Centre.